Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 6, 2005 - Issue 15
Submit an article Journal homepage
185
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluation

Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder

Bernardo Dell’Osso Compulsive, Impulsive and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1230, New York, NY 10029, USA. [email protected]
,
Andrea Allen Compulsive, Impulsive and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1230, New York, NY 10029, USA. [email protected]
&
Eric Hollander Compulsive, Impulsive and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1230, New York, NY 10029, USA. [email protected]
Pages 2727-2740 | Published online: 30 Nov 2005

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Masatomo Ishikawa & Kenji Hashimoto. (2010) The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases. Journal of Receptor, Ligand and Channel Research 3, pages 25-36.
Read now
Lídia Ordacgi, Mauro V Mendlowicz & Leonardo F Fontenelle. (2009) Management of obsessive-compulsive disorder with fluvoxamine extended release. Neuropsychiatric Disease and Treatment 5, pages 301-308.
Read now

Articles from other publishers (14)

Alexandra Wendler & Martin Wehling. (2023) Translatability scoring in prospective and retrospective COVID drug development cases. European Journal of Clinical Pharmacology 79:8, pages 1051-1071.
Crossref
Tomasz Kosmalski, Daria Kupczyk, Szymon Baumgart, Renata Paprocka & Renata Studzińska. (2023) A Review of Biologically Active Oxime Ethers. Molecules 28:13, pages 5041.
Crossref
Vera Nezgovorova, Casara Jean Ferretti, Stefano Pallanti & Eric Hollander. (2022) Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder. Journal of Psychiatric Research 149, pages 367-373.
Crossref
Veronica B. Maphanga, Krystyna Skalicka-Wozniak, Barbara Budzynska, Andriana Skiba, Weiyang Chen, Clement Agoni, Gill M. Enslin & Alvaro M. Viljoen. (2022) Mesembryanthemum tortuosum L. alkaloids modify anxiety-like behaviour in a zebrafish model. Journal of Ethnopharmacology 290, pages 115068.
Crossref
Dimple Gupta, Akansha Bhardwaj, Rashmi Prakash & Nimmi Jose. (2022) Fluvoxamine-induced tics: A rare phenomenon. Archives of Medicine and Health Sciences 10:2, pages 274.
Crossref
Vikas P. Sukhatme, Angela M. Reiersen, Sharat J. Vayttaden & Vidula V. Sukhatme. (2021) Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19. Frontiers in Pharmacology 12.
Crossref
NithyanandaS Murthy, BP Nirmala, RDhanasekara Pandian & YC Janardhan Reddy. (2020) Resilience and sociooccupational functioning among caregivers of obsessive-compulsive disorder. Archives of Mental Health 21:2, pages 59.
Crossref
Doug Hyun Han, Gi Jung Hyun, Jeong Ha Park & Perry F. Renshaw. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse 955 961 .
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 111 143 .
Z. Whitney, R. M. Procyshyn, D. H. Fredrikson & A. M. Barr. (2015) Treatment of clozapine-associated weight gain: a systematic review. European Journal of Clinical Pharmacology 71:4, pages 389-401.
Crossref
Doug Hyun Han, Sun Mi Kim & Perry F. Renshaw. 2015. Internet Addiction. Internet Addiction 77 91 .
Addy van Dijk, Andre Klompmakers & Damiaan Denys. 2010. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin 547 563 .
Daniela Perani, Valentina Garibotto, Alessandra Gorini, Rosa Maria Moresco, Marta Henin, Andrea Panzacchi, Mario Matarrese, Assunta Carpinelli, Laura Bellodi & Ferruccio Fazio. (2008) In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder. NeuroImage 42:1, pages 306-314.
Crossref
Damiaan Denys. (2006) Pharmacotherapy of Obsessive-compulsive Disorder and Obsessive-Compulsive Spectrum Disorders. Psychiatric Clinics of North America 29:2, pages 553-584.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.